Lakefront Biotherapeutics | GLPG - Sales Revenues

Stock Price
23.40
Daily Change
-0.38 -1.60%
Monthly
-5.26%
Yearly
-5.11%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR6.5M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
argenx SE USD 1.12B 0 Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
Biogen USD 2.25B 30M Mar/2026
Genmab DKK 1.06B 36M Dec/2025
Gilead Sciences USD 7B 930M Mar/2026
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Incyte USD 1.27B 240M Mar/2026
Merck EUR 5.13B 120M Mar/2026
Neurocrine Biosciences USD 811M 5.5M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
UCB EUR 4.25B 764M Dec/2025
Vertex Pharmaceuticals USD 2.99B 200M Mar/2026